Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in AUD
The 3 analysts offering 12 month price targets for Radiopharm Theranostics Ltd have a median target of 0.28, with a high estimate of 0.75 and a low estimate of 0.07. The median estimate represents a 775.00% increase from the last price of 0.032.
High | 2,243.8% | 0.75 |
Med | 775.0% | 0.28 |
Low | 118.8% | 0.07 |
Earnings history & estimates in AUD
Average growth rate | +6.86% |
More ▼
Revenue history & estimates in AUD
Average growth rate | +2.40% |
More ▼